{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:06Z","timestamp":1762866126795},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11096-012-9744-x","type":"journal-article","created":{"date-parts":[[2013,3,27]],"date-time":"2013-03-27T13:59:36Z","timestamp":1364392776000},"page":"386-392","source":"Crossref","is-referenced-by-count":1,"title":["Worldwide analysis of factors associated with medicines compendia publishing"],"prefix":"10.1007","volume":"35","author":[{"given":"Blanca","family":"Arguello","sequence":"first","affiliation":[]},{"given":"Fernando","family":"Fernandez-Llimos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"9744_CR1","first-page":"211","volume":"25","author":"WA Parker","year":"1979","unstructured":"Parker WA. The compendium of pharmaceuticals and specialties as a drug information resource for treatment of acute drug overdose. Can Fam Physician. 1979;25:211\u20135.","journal-title":"Can Fam Physician"},{"key":"9744_CR2","first-page":"265","volume":"35","author":"JW Ely","year":"1992","unstructured":"Ely JW, Burch RJ, Vinson DC. The information needs of family physicians: case-specific clinical questions. J Fam Pract. 1992;35:265\u20139.","journal-title":"J Fam Pract"},{"key":"9744_CR3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.161.6.880","volume":"161","author":"JS Cohen","year":"2001","unstructured":"Cohen JS. Adverse drug effects, compliance, and initial doses of antihypertensive drugs recommended by the Joint National Committee vs the Physicians\u2019 Desk Reference. Arch Intern Med. 2001;161:880\u20135.","journal-title":"Arch Intern Med"},{"key":"9744_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6955-5-5","volume":"5","author":"AL Murphy","year":"2006","unstructured":"Murphy AL, Fleming M, Martin-Misener R, Sketris IS, Maccara M, Gass D. Drug information resources used by nurse practitioners and collaborating physicians at the point of care in Nova Scotia, Canada: a survey and review of the literature. BMC Nurs. 2006;5:5.","journal-title":"BMC Nurs"},{"key":"9744_CR5","first-page":"206","volume":"93","author":"JE Andrews","year":"2005","unstructured":"Andrews JE, Pearce KA, Ireson C, Love MM. Information-seeking behaviors of practitioners in a primary care practice-based research network (PBRN). J Med Libr Assoc. 2005;93:206\u201312.","journal-title":"J Med Libr Assoc"},{"key":"9744_CR6","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1345\/aph.1L255","volume":"42","author":"CM Wong","year":"2008","unstructured":"Wong CM, Ko Y, Chan A. Clinically significant drug\u2013drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia. Ann Pharmacother. 2008;42:1737\u201348.","journal-title":"Ann Pharmacother"},{"key":"9744_CR7","unstructured":"Laing R, Tisocki K. How to develop a national formulary based on the WHO model formulary: a practical guide. Geneve: WHO; 2004."},{"key":"9744_CR8","unstructured":"American Society of Health-System Pharmacists. AHFS drug information. Washington, DC. http:\/\/www.ahfsdruginformation.com\/products_services\/di_ahfs.aspx . Accessed 1 Oct 2012."},{"key":"9744_CR9","unstructured":"Truven Health Analytics. DRUGDEX system. Ann Arbor, MI. http:\/\/www.truvenhealth.com\/your_healthcare_focus\/hospital_patient_care_decisions\/medication_management.aspx . Accessed 1 Oct 2012."},{"key":"9744_CR10","unstructured":"Elsevier. Clinical pharmacology. Tampa, FL. http:\/\/www.clinicalpharmacology.com\/ . Accessed 1 Oct 2012."},{"key":"9744_CR11","unstructured":"National Comprehensive Cancer Network. NCCN drugs and biologics compendium (NCCN compendium\u00ae). Fort Washington, PA. http:\/\/www.nccn.org\/professionals\/drug_compendium\/content\/contents.asp . Accessed 1 Oct 2012."},{"key":"9744_CR12","unstructured":"PDR books. 2013 Physicians\u2019 Desk Reference\u00ae. Chestertown, MD. http:\/\/www.pdrbooks.com\/prod\/2013-Editions\/Product-Catalog_95\/2013-Physicians-Desk-Reference-_89.aspx . Accessed 1 Oct 2012."},{"key":"9744_CR13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00228-008-0604-5","volume":"65","author":"U Hedegaard","year":"2009","unstructured":"Hedegaard U, Damkier P. Problem-oriented drug information: physicians\u2019 expectations and impact on clinical practice. Eur J Clin Pharmacol. 2009;65:515\u201322.","journal-title":"Eur J Clin Pharmacol"},{"key":"9744_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-1842.2007.00713.x","volume":"24","author":"K Davies","year":"2007","unstructured":"Davies K, Harrison J. The information-seeking behaviour of doctors: a review of the evidence. Health Info Libr J. 2007;24:78\u201394.","journal-title":"Health Info Libr J"},{"key":"9744_CR15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archinte.161.7.957","volume":"161","author":"JS Cohen","year":"2001","unstructured":"Cohen JS. Dose discrepancies between the Physicians\u2019 Desk Reference and the medical literature, and their possible role in the high incidence of dose-related adverse drug events. Arch Intern Med. 2001;161:957\u201364.","journal-title":"Arch Intern Med"},{"key":"9744_CR16","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3109\/14767051003653252","volume":"23","author":"MA Morgan","year":"2010","unstructured":"Morgan MA, Cragan JD, Goldenberg RL, Rasmussen SA, Schulkin J. Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy. J Matern Fetal Neonatal Med. 2010;23:1143\u201350.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"9744_CR17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2125.2006.02809.x","volume":"63","author":"AI Vitry","year":"2007","unstructured":"Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol. 2007;63:709\u201314.","journal-title":"Br J Clin Pharmacol"},{"key":"9744_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2125.2006.02687.x","volume":"62","author":"G Trifiro","year":"2006","unstructured":"Trifiro G, Corrao S, Alacqua M, Moretti S, Tari M, Caputi AP, Arcoraci V. Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources. Br J Clin Pharmacol. 2006;62:582\u201390.","journal-title":"Br J Clin Pharmacol"},{"key":"9744_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2125.2008.03322.x","volume":"67","author":"AJ Wall","year":"2009","unstructured":"Wall AJ, Bateman DN, Waring WS. Variability in the quality of overdose advice in summary of product characteristics (SPC) documents: gut decontamination recommendations for CNS drugs. Br J Clin Pharmacol. 2009;67:83\u20137.","journal-title":"Br J Clin Pharmacol"},{"key":"9744_CR20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00228-003-0607-1","volume":"59","author":"V Reggi","year":"2003","unstructured":"Reggi V, Balocco-Mattavelli R, Bonati M, Breton I, Figueras A, Jambert E, Kopp C, Montane E, Rago L, Rocchi F. Prescribing information in 26 countries: a comparative study. Eur J Clin Pharmacol. 2003;59:263\u201370.","journal-title":"Eur J Clin Pharmacol"},{"key":"9744_CR21","first-page":"95","volume":"55","author":"M Warner-Smith","year":"2003","unstructured":"Warner-Smith M. The challenge of developing drug information systems in Africa. Bull Narcot. 2003;55:95\u20138.","journal-title":"Bull Narcot"},{"key":"9744_CR22","first-page":"21","volume":"18","author":"C Flores","year":"2004","unstructured":"Flores C. Drug Information Centers in developing countries and the promotion of rational use of drugs: a viewpoint about challenges and perpectives. Int Pharm J. 2004;18:21\u20133.","journal-title":"Int Pharm J"},{"key":"9744_CR23","unstructured":"US Congress Office of Technology Assessment. Drug labeling in developing countries. Washington: U.S. Government Printing Office; 1993. ISBN: 0-16-041628-0."},{"key":"9744_CR24","unstructured":"World Health Organization. Index of pharmacopoeias. Geneve: WHO; 2006. http:\/\/www.who.int\/medicines\/areas\/quality_safety\/quality_assurance\/resources\/index-of-pharmacopoeias16032012.pdf . Accessed May 2012."},{"key":"9744_CR25","unstructured":"U.S. Department of State. Independent States in the World. Washington, DC. http:\/\/www.state.gov\/s\/inr\/rls\/4250.htm . Accessed 29 Aug 2011."},{"key":"9744_CR26","unstructured":"The World Bank. Data: the World Bank. Washington, DC. http:\/\/data.worldbank.org\/ . Accessed 30 Aug 2011."},{"key":"9744_CR27","unstructured":"World Health Organization. WHO: data and statistics. Geneve: WHO. http:\/\/www.who.int\/research\/en\/ . Accessed 30 Aug 2011."},{"key":"9744_CR28","volume-title":"Gulf cooperation council healthcare industry","author":"Alpen Capital","year":"2009","unstructured":"Capital Alpen. Gulf cooperation council healthcare industry. Dubai: Alpen Capital; 2009."},{"key":"9744_CR29","unstructured":"OECD. Organisation for Economic Co-Operation And Development (OECD). Paris. http:\/\/www.oecd.org . Accessed 04 Sept 2011."},{"key":"9744_CR30","unstructured":"OECD: Chair of the Heads of Delegation Working Group on the Enlargement Strategy and Outreach ASN. A strategy for enlargement and outreach. Paris: OECD; 2004."},{"key":"9744_CR31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1592\/phco.28.8.992","volume":"28","author":"FW Frueh","year":"2008","unstructured":"Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy. 2008;28:992\u20138.","journal-title":"Pharmacotherapy"},{"key":"9744_CR32","unstructured":"World Health Organization. WHO model formulary. Geneve: WHO; 2008. ISBN 978-92-4-154765-9."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9744-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-012-9744-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-012-9744-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:54:40Z","timestamp":1559368480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-012-9744-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9744"],"URL":"https:\/\/doi.org\/10.1007\/s11096-012-9744-x","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}